Promising
Assistive and other devices: improve symptoms or function in relapsing MS
relapsing MS · Assistive and other devices
A controlled phase 2 trial was positive. Phase 2 trials are small and often measure early markers, so this is a signal, not proof.
- Trials
- 4
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 42
How the verdict was reached
Positive in phase 2 only
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| EMST | Phase2|phase3 | 42 | 2009 | Met its main goal | Counted |
| FINGER | Not a drug-phase study | 10 | 2013 | Stopped | Not counted: not randomised |
| Dimethyl fumarate, phase 4 | Phase 4 | 84 | 2015 | Stopped | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 95 | 2014 | No results found | Not counted: not randomised |
Counted: 1. Will count later: 0. Not counted: 3.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Nov 2026Trials: 5 → 4
- Oct 2026Trials: 14 → 5
- Oct 2026Status changed from Being tested to Promising
- Oct 2026Trials: 11 → 14
- Oct 2026Status changed from Confirmed to Being tested
- Oct 2026First listed as Confirmed
Related hypotheses
- Assistive and other devices: improve symptoms or function in NMOSD
- Assistive and other devices: improve symptoms or function in primary progressive MS
- Assistive and other devices: improve symptoms or function in relapsing and progressive MS
- Assistive and other devices: improve symptoms or function in MS (type not specified)
Assembled by software from public sources.